Background Endometrial biopsies are undertaken in premenopausal women with abnormal
uterine bleeding but the risk of endometrial cancer or atypical hyperplasia is unclear …

Objectives Hormonal therapies have been associated with a range of effects on the
endometrium, including endometrial hyperplasia (EH). With many medicinal products being …

Objective. To create a prediction model including clinical variables for the prediction of
premalignant/malignant endometrial pathology in premenopausal women with abnormal …

Aims: To estimate the recurrence rate of patients with endometrial polyps and to evaluate
whether the recurrence can be correlated with the histopathologic features of the polyp …

Objective This study aimed to evaluate risk factors for endometrial intraepithelial
neoplasia/malignancy in premenopausal women with abnormal uterine bleeding or …

Purpose This study aimed to identify the risk factors and sonographic variables that could be
integrated into a predictive model for endometrial cancer (EC) and atypical endometrial …

Objective To estimate the prevalence of, and identify risk factors associated with,
endometrial hyperplasia and/or cancer (EH/EC) in patients≤ 45 years old undergoing …

Purpose To evaluate the role of body mass index (BMI) in women with premenopausal
heavy menstrual bleeding (HMB) to identify patients who should undergo endometrial …

Background: Our aim was to compare the therapeutic efficacies of norethisterone acid
(NETA), tranexamic acid and levonorgestrel-releasing intrauterine system (LNG-IUS) in …

Background and Objectives To determine the rate of significant endometrial abnormalities in
premenopausal women at low risk for endometrial hyperplasia and cancer presenting with …